Belgium· BE-AMP-SAM325105-00

Vimpat 100 mg

A lacosamide product containing lacosamide, registered in Belgium by UCB Pharma. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX18

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lacosamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lacosamide is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX18 (lacosamide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search lacosamide products by name

Lacosamide · ATC N03AX18

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lacosamide costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.48 in United States to $3.11 in Switzerland — a ×6.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Lacosamide · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$3.11
IT Italy$3.06
FR France$1.49
US United States$0.48 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Lacosamide
Manufacturer: UCB Pharma
Country: Belgium (BE)
ATC code: N03AX18
ATC class: Lacosamide
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

1 priced

be_apb
2548287
EUR 37.46
be_apb
0796300
be_apb
2962090

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

62 interactions on record for lacosamide.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lacosamide against other medicines How interaction checks work

Lacosamide · interactions on record

62 records

5 severe
32 moderate

Most severe, free to view

DolasetronA04AA04severe
CeritinibL01ED02severe
CeritinibL01XE28severe
SiponimodL04AA42severe

25 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lacosamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lacosamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Lacopat, Lacopat Packung Zur Behandlungseinleitung
Bulgaria · Канилад, Лакозамид Гриндекс
Cyprus · Kanilad, Lacosadel
Czechia · Arkvimma, Kanilad
Germany · Kanilad, Lackepila
Denmark · 200 mg, Lacosamid Opko Health Spain
Estonia · Kanilad, Lacosamide Alembic
Spain · Balmid, Kanilad
Finland · Lacosamide Fresenius Kabi, Lacosamide Grindeks
France · Lacosamide Arrow, Lacosamide Biogaran
United Kingdom (Northern Ireland) · Lacosamide, Lacosamide Amarox
Greece · Anlamyl, Josamec
Croatia · Kanilad, Lacosamide Grindeks
Hungary · Anlamyl, Arkvimma
Ireland · Lacosamide Ascend, Lacosamide Fresenius Kabi
Iceland · Josamec, Lacosamide Accord
Italy · Lacosamide Aurobindo, Lacosamide Doc
Liechtenstein · Lacosamid Fresenius Kabi, Lacosamide Accord
Lithuania · Lacosamide Fresenius Kabi, Lacosamide Grindeks
Luxembourg · Lacosamide Eg
Latvia · Kanilad, Lacosamide Fresenius Kabi
Malta · Anlamyl, Kanilad
Netherlands · Cosim, Lacosamide Amarox
Norway · Lacosamide Accord, Lacosamide Fresenius Kabi
Poland · Arkvimma, Epilantin
Portugal · Lacosamida Alter, Lacosamida Aristo
Romania · Lacosamidă Teva
Sweden · Lacomed, Lacosamide 1a Farma
Slovenia · Lacosabil, Lacosamide Grindeks
Slovakia · Arkvimma, Kanilad

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f99cc783-dbc2-4a83-ac18-090d0f187b73
GET /v1/drugs/f99cc783-dbc2-4a83-ac18-090d0f187b73?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Vimpat 100 mg",
  "name_fr": "Vimpat 100 mg",
  "name_nl": "Vimpat 100 mg",
  "amp_code": "SAM325105-00",
  "strengths": [
    "100.0000",
    "100.0000"
  ],
  "pack_count": 7,
  "substances": [
    "Lacosamide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lacosamide",
  "authorisation_numbers": [
    "EU/1/08/470/004",
    "EU/1/08/470/005",
    "EU/1/08/470/006",
    "EU/1/08/470/021",
    "EU/1/08/470/026",
    "EU/1/08/470/027",
    "EU/1/08/470/033"
  ]
}

API reference MCP server Plans

See everything about lacosamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console